India
· Delayed Price · Currency is INR Eris Lifesciences Statistics
Total Valuation
NSE:ERIS has a market cap or net worth of INR 200.73 billion. The enterprise value is 229.71 billion.
| Market Cap | 200.73B |
| Enterprise Value | 229.71B |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | Feb 13, 2025 |
Share Statistics
NSE:ERIS has 136.16 million shares outstanding. The number of shares has decreased by -0.03% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 136.16M |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 60.48% |
| Owned by Institutions (%) | 23.93% |
| Float | 40.77M |
Valuation Ratios
The trailing PE ratio is 60.97 and the forward PE ratio is 40.31. NSE:ERIS's PEG ratio is 1.34.
| PE Ratio | 60.97 |
| Forward PE | 40.31 |
| PS Ratio | 7.37 |
| PB Ratio | 6.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.34 |
Enterprise Valuation
| EV / Earnings | 69.75 |
| EV / Sales | 8.43 |
| EV / EBITDA | 26.97 |
| EV / EBIT | 36.82 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.86 |
| Debt / EBITDA | 3.21 |
| Debt / FCF | n/a |
| Interest Coverage | 2.97 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.50% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 7.52M |
| Profits Per Employee | 909,815 |
| Employee Count | 3,620 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +71.23% in the last 52 weeks. The beta is 0.12, so NSE:ERIS's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +71.23% |
| 50-Day Moving Average | 1,323.36 |
| 200-Day Moving Average | 1,301.32 |
| Relative Strength Index (RSI) | 69.81 |
| Average Volume (20 Days) | 159,349 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ERIS had revenue of INR 27.24 billion and earned 3.29 billion in profits. Earnings per share was 24.18.
| Revenue | 27.24B |
| Gross Profit | 20.46B |
| Operating Income | 6.24B |
| Pretax Income | 4.37B |
| Net Income | 3.29B |
| EBITDA | 8.40B |
| EBIT | 6.24B |
| Earnings Per Share (EPS) | 24.18 |
Balance Sheet
The company has 2.43 billion in cash and 27.35 billion in debt, giving a net cash position of -24.92 billion or -183.04 per share.
| Cash & Cash Equivalents | 2.43B |
| Total Debt | 27.35B |
| Net Cash | -24.92B |
| Net Cash Per Share | -183.04 |
| Equity (Book Value) | 31.77B |
| Book Value Per Share | 203.65 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.10%, with operating and profit margins of 22.90% and 12.09%.
| Gross Margin | 75.10% |
| Operating Margin | 22.90% |
| Pretax Margin | 16.05% |
| Profit Margin | 12.09% |
| EBITDA Margin | 30.84% |
| EBIT Margin | 22.90% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 7.35, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | 7.35 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.03% |
| Shareholder Yield | 0.56% |
| Earnings Yield | 1.64% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |